Current Status of Cell-Based Therapy in Patients with Critical Limb Ischemia

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61988987%3A17110%2F20%3AA21026L0" target="_blank" >RIV/61988987:17110/20:A21026L0 - isvavai.cz</a>
Alternative codes found
RIV/00843989:_____/20:E0108655
Result on the web
<a href="https://www.mdpi.com/1422-0067/21/23/8999" target="_blank" >https://www.mdpi.com/1422-0067/21/23/8999</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.20944/preprints202011.0193.v1" target="_blank" >10.20944/preprints202011.0193.v1</a>

Result language
angličtina
Original language name
Current Status of Cell-Based Therapy in Patients with Critical Limb Ischemia
Original language description
The treatment of peripheral arterial disease (PAD) is focused on improving perfusion and oxygenation in the affected limb. Standard revascularization methods include bypass surgery, endovascular interventional procedures, or hybrid revascularization. Cell-based therapy can be an alternative strategy for patients with no-option critical limb ischemia who are not eligible for endovascular or surgical procedures. Aims: This review offers an up-to-date critical overview of the knowledge and data of evidence-based medicine on the position of cell therapy in the treatment of PAD. It provides an overview of current evidence and appraises the future perspectives of cellbased therapy, emphasizing the potential of exosomal cell-free approaches in patients with critical limb ischemia.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10608 - Biochemistry and molecular biology

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)